SCHEDULE 13G/A: CVI Investments and Heights Capital Disclose 4.9% Stake in Microbot Medical Inc.
Beneficial Ownership Disclosure
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly disclosed a beneficial ownership of 4.9% in Microbot Medical Inc., totaling 1,824,807 shares.
Summary
- CVI Investments, Inc. and Heights Capital Management, Inc. (collectively, 'Reporting Persons') have filed an amended Schedule 13G, disclosing their beneficial ownership in Microbot Medical Inc.
- The Reporting Persons collectively beneficially own 1,824,807 shares of Microbot Medical Inc. common stock.
- This ownership represents 4.9% of the company's outstanding common stock.
- The shares reported as beneficially owned consist of shares issuable upon the exercise of warrants to purchase shares.
- The warrants are subject to a limitation, not exercisable to the extent that total beneficial ownership by a Reporting Person and its affiliates would exceed 4.99%.
- As of March 25, 2025, Microbot Medical Inc. had 34,744,476 shares outstanding, as indicated in the company's Prospectus filed on April 8, 2025.
Sentiment
Score: 5
Explanation: This is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative operational or financial news about the company.
Future Outlook
NA
Management Comments
- Brian Sopinsky, Secretary of Heights Capital Management, Inc., certified that, to the best of his knowledge and belief, the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.
Industry Context
This filing is a standard disclosure of beneficial ownership by institutional investors, indicating their stake in a publicly traded company. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by institutional investors like CVI Investments and Heights Capital Management may be viewed positively by other shareholders, potentially signaling institutional confidence or interest in the company.
Key Dates
| Date | Description |
|---|---|
| 03/25/2025 | Date as of which Microbot Medical Inc. had 34,744,476 shares outstanding. |
| 03/31/2025 | Date of event which requires filing of this statement. |
| 04/08/2025 | Date Microbot Medical Inc.'s Prospectus (Registration No. 333-284688) was filed. |
| 05/12/2025 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
Microbot Medical Inc., CVI Investments, Heights Capital Management, Beneficial Ownership, Schedule 13G, Common Stock, Warrants, Institutional Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.